| A meta-analysis to determine the effect of pharmacological and non-pharmacological treatments on fibromyalgia symptoms comprising OMERACT-10 response criteria D Papadopoulou, A Fassoulaki, C Tsoulas, I Siafaka, A Vadalouca Clinical Rheumatology 35, 573-586, 2016 | 52 | 2016 |
| Invasive candidiasis: update on current pharmacotherapy options and future perspectives A Tragiannidis, C Tsoulas, K Kerl, AH Groll Expert opinion on pharmacotherapy 14 (11), 1515-1528, 2013 | 48 | 2013 |
| Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer? C Tsoulas, D Nathwani International journal of antimicrobial agents 46 (1), 1-7, 2015 | 37 | 2015 |
| Invasive candidiasis and candidaemia in neonates and children: update on current guidelines A Tragiannidis, C Tsoulas, AH Groll Mycoses 58 (1), 10-21, 2015 | 35 | 2015 |
| Role of vaccinations and prophylaxis in rheumatic diseases D Papadopoulou, C Tsoulas, A Tragiannidis, NV Sipsas Best practice & research Clinical rheumatology 29 (2), 306-318, 2015 | 20 | 2015 |
| Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek … K Athanasakis, I Petrakis, M Ollandezos, C Tsoulas, DA Patel, E Karampli, ... Infectious Diseases and Therapy 3, 257-268, 2014 | 18 | 2014 |
| Aiming towards hepatitis C virus elimination in Greece GV Papatheodoridis, J Goulis, V Sypsa, C Lionis, S Manolakopoulos, ... Annals of gastroenterology 32 (4), 321, 2019 | 17 | 2019 |
| Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis H Kranidioti, C Chatzievagelinou, A Protopapas, M Papatheodoridi, ... Annals of gastroenterology 31 (5), 598, 2018 | 4 | 2018 |
| The burden of initial empiric antibiotic failure on healthcare resources for hospitalized patients with complicated intra-abdominal infections in Greece C Tsoulas, I Petrakis, K Athanasakis, A Vatopoulos, K Vagianos Hellenic Journal of Surgery 85, 215-223, 2013 | 2 | 2013 |
| Health-economic evaluation of fast-track hepatitis C micro-elimination program among people who inject drugs receiving oral substitution therapy in the hellenic organization … I Gountas, O Anagnostou, E Petroulaki, K Kokkolis, A Dimitriadis, ... Hepatology 74, 591A-592A, 2021 | 1 | 2021 |
| The potential impact of drug-drug interactions (DDIs) in the selection of direct acting antivirals (DDAs) in the current treatment of chronic hepatitis C (CHC) in routine … GV Papatheodoridis, J Goulis, S Manolakopoulos, CK Triantos, K Zachou, ... Hepatology 63 (1 SUPP), 489A-489A, 2016 | 1 | 2016 |
| Medical and adjunctive treatment of mucormycosis in children: Scientific rationale and analysis of cases reported in the literature C Tsoulas, A Tragiannidis, AH Groll Current Fungal Infection Reports 8, 12-20, 2014 | 1 | 2014 |
| Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece E Sinakos, N Kachru, C Tsoulas, S Jeyakumar, NJ Smith, A Yehoshua, ... Journal of Comparative Effectiveness Research, e230090, 2024 | | 2024 |
| Cost-effectiveness Analysis and Impact on Length of Hospital Stay of the Introduction of Remdesivir as a Treatment Option for Hospitalized Patients With COVID-19 Requiring … K Athanasakis, K Zisis, C Tsoulas, N Nomikos Clinical Therapeutics 45 (12), 1244-1250, 2023 | | 2023 |
| EE128 Cost-Effectiveness of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Vs. Entecavir for Chronic Hepatitis B Patients in Greece E Sinakos, N Kachru, C Tsoulas, S Jeyakumar, N Smith, A Yehoshua, ... Value in Health 26 (6), S82-S83, 2023 | | 2023 |
| EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece K Athanasakis, N Nomikos, C Tsoulas, K Zisis Value in Health 25 (12), S159, 2022 | | 2022 |
| Mild alcohol consumption and risk for cardiovascular disease in patients with non-alcoholic steatohepatitis: data from a multicenter observational study. S SAVVIDOU, M PAPATHEODORIDI, K ZISIMOPOULOS, K KOUSTENIS, ... Hypertension 211 (26), 2, 2021 | | 2021 |
| Epidemiology and severity of non-alcoholic fatty liver disease in Greek tertiary liver centres S Savvidou, M Papatheodoridi, K Zisimopoulos, K Koustenis, ... Gastroenterol Hepatol 5, 1-8, 2020 | | 2020 |
| EPIDEMIOLOGICAL GREEK MULTICENTER STUDY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM A LARGE NATIONAL COHORT S Savvidou, T Voulgaris, K Zisimopoulos, K Koustenis, DN Samonakis, ... HEPATOLOGY 70, 751A-752A, 2019 | | 2019 |
| ASSESSMENT OF NON-INVASIVE TOOLS TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM A LARGE NATIONAL COHORT S Savvidou, M Papatheodoridi, K Zisimopoulos, K Koustenis, ... HEPATOLOGY 70, 1069A-1070A, 2019 | | 2019 |
George PapatheodoridisNational and Kapodistrian University of Athens, Medical SchoolVerified email at med.uoa.gr
